Buy & Sell Jabil Inc (JBL) – Jabil Inc Price Today
Aura AI Summary
Key Stats
- $39.56BMarket Cap
- TechnologySector
- -12.63%3M Drawdown
- $42.12BEnterprise Value
- 0.09%Dividend Yield
- 64% Buy | 36% SellTrading Activity
- 12 daysTypical Hold Time
Jabil Inc (JBL) is currently valued at a market capitalization of $39.56B, with an enterprise value of $42.12B. Over the past 52 weeks, Jabil Inc has traded between a low of $192.49 and a high of $385.48, highlighting its annual price range. Over the past three months, Jabil Inc has recorded a drawdown of -12.63%, reflecting recent price volatility. Jabil Inc offers a dividend yield of 0.09%, with the most recent dividend of $0.08 paid on 15 May 26. On average, investors hold Jabil Inc for approximately 12 days, indicating typical investor behavior on the platform.
About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Most Recent News
Over 100 drugs in clinical trials aim to transform age-related macular degeneration treatment by 2026
DelveInsight's 2026 report reveals more than 100 drugs in development for age-related macular degeneration (AMD), involving over 90 companies globally. These therapies include novel mechanisms like gene therapy, mitochondrial stabilization, and VEGF ...

Cell and gene therapy CDMO market set to grow at 24% CAGR, reaching $57.1B by 2034.
The cell and gene therapy contract development and manufacturing organization (CDMO) market is projected to grow at a compound annual growth rate (CAGR) of approximately 24% from 2026 to 2034, reaching a market size of $57.1 billion by 2034. Growth i...

Polymeric biomaterials market to hit $267B by 2034, driven by regenerative medicine and healthcare growth.
The global polymeric biomaterials market, valued at $69.55 billion in 2024, is projected to grow at a CAGR of 15.86% to reach $267.25 billion by 2034. Growth is fueled by increasing demand in regenerative medicine, orthopedics, and wound care, with A...
